Advertisement

CardioVascular and Interventional Radiology

, Volume 39, Issue 10, pp 1491–1498 | Cite as

Percutaneous MR-Guided Cryoablation of Morton’s Neuroma: Rationale and Technical Details After the First 20 Patients

  • Roberto Luigi CazzatoEmail author
  • Julien Garnon
  • Nitin Ramamurthy
  • Georgia Tsoumakidou
  • Jean Caudrelier
  • Marie-Aude Thenint
  • Pramod Rao
  • Guillaume Koch
  • Afshin Gangi
Technical Note

Abstract

Objectives

The purpose of this study is to discuss technical aspects and rationales of magnetic resonance (MR)-guided cryoablation (CA) of Morton’s neuroma (MN); preliminary clinical experience is also retrospectively reviewed.

Methods

Procedures were performed under local anaesthesia on an outpatient basis. Lesion size and location, procedural (technical success, procedural time, complications) and clinical outcomes (patient satisfaction according to a four-point scale, residual pain according to a 0–10 visual analogue scale and instances of “stump neuroma”) were assessed via chart review and cross-sectional telephone survey after the 20th case.

Results

Twenty patients (15 female, 5 male; mean age 50.3 years) were included; 24 MN (mean size 12.7 mm) were treated. Technical success was 100 %. Mean procedural time was 40.9 ± 10.4 min (range 35–60). One minor complication (superficial cellulitis) was reported (4.2 %). Follow-up (mean 19.7 months) was available for 18/24 MN. Patient satisfaction on a per-lesion basis was as follows: “completely satisfied” in 77.7 %, “satisfied with minor reservations” in 16.6 % and “satisfied with major reservations” in 5.7 % of cases. Mean pain score at last follow-up post-CA was 3.0. No instances of “stump neuroma” were reported.

Conclusions

MR-guided CA of MN is a novel therapy which appears technically feasible. Clinical advantages of the procedure are high patient satisfaction, reduced risk of “stump neuroma” syndrome and good patient tolerance on an outpatient basis. Further, prospective studies are needed to confirm these encouraging results.

Keywords

Morton’s neuroma Magnetic resonance imaging Interventional Cryosurgery Percutaneous ablation technique 

Notes

Compliance with Ethical Standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest. Authors #1, #3, #5, #6, #7, #8 and #9 have no conflict of interest to disclose. Authors #2, #4 and #10 are proctor for Galil Medical, Inc.

Human and animal rights informed consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Morton TG. A peculiar and painful affection of the fourth metatarsophalangeal articulation. Am J Med Sci. 1876;71(141):37–45.CrossRefGoogle Scholar
  2. 2.
    Lee MJ, Kim S, Huh YM, Song HT, Lee SA, Lee JW, Suh JS. Morton neuroma: evaluated with ultrasonography and MR imaging. Korean J Radiol. 2007;8(2):148–55.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Morscher E, Ulrich J, Dick W. Morton’s interdigital neuroma: morphology and histological substrate. Foot Ankle Int. 2000;21:558–62.PubMedGoogle Scholar
  4. 4.
    Hassouna H, Singh D. Morton’s metatarsalgia: pathogenesis, aetiology and current management. Acta Orthop Belg. 2005;71(6):646–55.PubMedGoogle Scholar
  5. 5.
    Thomson CE, Gibson JN, Martin D. Interventions for the treatment of Morton’s neuroma. Cochrane Database Syst Rev. 2004;3(3):1–14.Google Scholar
  6. 6.
    Thomson CE, Beggs I, Martin DJ, McMillan D, Edwards RT, Russell D, Yeo ST, Russell IT, Gibson JN. Methylprednisolone injections for the treatment of Morton neuroma. J Bone Jt Surg Am. 2013;95:790–8.CrossRefGoogle Scholar
  7. 7.
    Kasparek M, Schneider W. Surgical treatment of Morton’s neuroma: clinical results after open excision. Int Orthop. 2013;37(9):1857–61.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kundert HP, Plaass C, Stukenborg-Colsman C, Waizy H. Excision of Morton’s neuroma using a longitudinal plantar approach: a midterm follow-up study. Foot Ankle Spec. 2015;. doi: 10.1177/1938640015599032.PubMedGoogle Scholar
  9. 9.
    Bauer T, Gaumetou E, Klouche S, Hardy P, Maffulli N. Metatarsalgia and Morton’s disease: comparison of outcomes between open procedure and neurectomy versus percutaneous metatarsal osteotomies and ligament release with a minimum of 2 years of follow-up. J Foot Ankle Surg. 2015;54(3):373–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Bennett GL, Graham CE, Mauldin DM. Morton’s interdigital neuroma: a comprehensive treatment protocol. Foot Ankle Int. 1995;16:760–3.CrossRefPubMedGoogle Scholar
  11. 11.
    Pasquali C, Vulcano E, Novario R, Varotto D, Montoli C, Volpe A. Ultrasound-guided alcohol injection for Morton’s neuroma. Foot Ankle Int. 2015;36(1):55–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Gurdezi S, White T, Ramesh P. Alcohol injection for Morton’s neuroma: a five-year follow-up. Foot Ankle Int. 2013;34(8):1064–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Chuter GS, Chua YP, Connell DA, Blackney MC. Ultrasound-guided radiofrequency ablation in the management of interdigital (Morton’s) neuroma. Skelet Radiol. 2013;42(1):107–11.CrossRefGoogle Scholar
  14. 14.
    Deniz S, Purtuloglu T, Tekindur S, Cansız KH, Yetim M, Kılıckaya O, Senkal S, Bilgic S, Atim A, Kurt E. Ultrasound-guided pulsed radio frequency treatment in Morton’s neuroma. J Am Podiatr Med Assoc. 2015;105(4):302–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Friedman T, Richman D, Adler R. Sonographically guided cryoneurolysis: preliminary experience and clinical outcomes. J Ultrasound Med. 2012;31(12):2025–34.PubMedGoogle Scholar
  16. 16.
    Hodor L, Barkal K, Hatch-Fox LD. Cryogenic denervation of the intermetatarsal space neuroma. J Foot Ankle Surg. 1997;36:311–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Caporusso EF, Fallat LM, Savoy-Moore R. Cryogenic neuroablation for the treatment of lower extremity neuromas. J Foot Ankle Surg. 2002;41:286–90.CrossRefPubMedGoogle Scholar
  18. 18.
    Cazzato RL, de Lara CT, Buy X, Ferron S, Hurtevent G, Fournier M, Debled M, Palussière J. Single-centre experience with percutaneous cryoablation of breast cancer in 23 consecutive non-surgical patients. Cardiovasc Interv Radiol. 2015;38(5):1237–43.CrossRefGoogle Scholar
  19. 19.
    Littrup PJ, Bang HJ, Currier BP, Goodrich DJ, Aoun HD, Heilbrun LK, Adam BA. Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol. 2013;24(12):1817–25.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Thompson SM, Callstrom MR, McKusick MA, Woodrum DA. Initial results of image-guided percutaneous ablation as second-line treatment for symptomatic vascular anomalies. Cardiovasc Interv Radiol. 2015;38(5):1171–8.CrossRefGoogle Scholar
  21. 21.
    Hsu M, Stevenson FF. Wallerian degeneration and recovery of motor nerves after multiple focused cold therapies. Muscle Nerve. 2015;51(2):268–75.CrossRefPubMedGoogle Scholar
  22. 22.
    Garnon J, Schlier A, Buy X, Tsoumakidou G, de Mathelin M, Breton E, Gangi A. Evaluation of percutaneous biopsies of renal masses under MRI-guidance: a retrospective study about 26 cases. Eur Radiol. 2015;25(3):617–23.CrossRefPubMedGoogle Scholar
  23. 23.
    Kerimaa P, Väänänen M, Ojala R, Hyvönen P, Lehenkari P, Tervonen O, Blanco Sequeiros RM. MRI-guidance in percutaneous core decompression of osteonecrosis of the femoral head. Eur Radiol. 2016;26(4):1180–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Schouten MG, Hoeks CM, Bomers JG, Hulsbergen-van de Kaa CA, Witjes JA, Thompson LC, Rovers MM, Barentsz JO, Fütterer JJ. Location of prostate cancers determined by multiparametric and MRI-guided biopsy in patients with elevated prostate-specific antigen level and at least one negative transrectal ultrasound-guided biopsy. Am J Roentgenol. 2015;205(1):57–63.CrossRefGoogle Scholar
  25. 25.
    Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, Saad WA, Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727–36.CrossRefPubMedGoogle Scholar
  26. 26.
    Sunderland S. Nerve and nerve injuries. 2nd ed. New York: Churchill Livingstone; 1978.Google Scholar
  27. 27.
    Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–202.CrossRefPubMedGoogle Scholar
  28. 28.
    Schon L. An injection of corticosteroid plus anesthetic was more effective than anesthetic alone for Morton neuroma. J Bone Jt Surg Am. 2014;96(4):334. doi: 10.2106/JBJS.9604.ebo028.CrossRefGoogle Scholar
  29. 29.
    Coughlin MJ, Pinsonneault T. Operative treatment of interdigital neuroma. A long-term follow-up study. J Bone Jt Surg Am. 2001;83:1321–8.Google Scholar
  30. 30.
    Pace A, Scammell B, Dhar S. The outcome of Morton’s neurectomy in the treatment of metatarsalgia. Int Orthop. 2010;34(4):511–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Giannini S, Bacchini P, Ceccarelli F, Vannini F. Interdigital neuroma: clinical examination and histopathologic results in 63 cases treated with excision. Foot Ankle Int. 2004;25:79–84.PubMedGoogle Scholar
  32. 32.
    Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M. Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int. 1994;15:349–53.CrossRefPubMedGoogle Scholar
  33. 33.
    Schreiber K, Khodaee M, Poddar S, Tweed EM. Clinical inquiry. What is the best way to treat Morton’s neuroma? J Fam Pract. 2011;60(3):157–8, 168.Google Scholar
  34. 34.
    Genon MP, Chin TY, Bedi HS, Blackney MC. Radio-frequency ablation for the treatment of Morton’s neuroma. ANZ J Surg. 2010;80(9):583–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Moore JL, Rosen R, Cohen J, Rosen B. Radiofrequency thermoneurolysis for the treatment of Morton’s neuroma. J Foot Ankle Surg. 2012;51:20–2.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2016

Authors and Affiliations

  • Roberto Luigi Cazzato
    • 1
    Email author
  • Julien Garnon
    • 1
  • Nitin Ramamurthy
    • 2
  • Georgia Tsoumakidou
    • 1
  • Jean Caudrelier
    • 1
  • Marie-Aude Thenint
    • 1
  • Pramod Rao
    • 1
  • Guillaume Koch
    • 1
  • Afshin Gangi
    • 1
  1. 1.Department of Interventional Radiology, Nouvel Hôpital CivilHôpitaux Universitaires de Strasbourg, HUS)StrasbourgFrance
  2. 2.Department of RadiologyNorfolk and Norwich University HospitalNorwichUK

Personalised recommendations